Vanguard Group »

Evoke Pharma shares owned by Vanguard Group

Quarter-by-quarter ownership of Evoke Pharma (EVOK) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Evoke Pharma

Tip: Access up to 7 years of quarterly data

All positions including Evoke Pharma held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evoke Pharma by Vanguard Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $93k 19k 4.97

More positions owned by Vanguard Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Exxon Mobil Corporation (XOM)
Oracle Corporation (ORCL)

View all positions for Vanguard Group

Top funds holding Evoke Pharma

Nantahala Capital Management
Bleichroeder
National Wealth Management Group
DRW Holdings
Vanguard Group
Two Sigma Securities
Advisor Group Holdings
Northwestern Mutual Wealth Management Company
Royal Bank of Canada
BlackRock
SBI Securities
Morgan Stanley
Tower Research Capital
Goss Wealth Management

View all funds holding Evoke Pharma